Skip to main content

Clinical Trials › NCT05605782

Active, Not Recruiting

A Post-Authorization, Long-term Study of Ozanimod Real-world Safety

Sponsored by Bristol-Myers Squibb

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
9000
Target enrollment
1
U.S. states
Sep 2021
Start date
Jul 2033
Expected completion

Conditions studied

Multiple Sclerosis, Relapsing-Remitting

Where this trial is running (1 site)

Maryland1 site
Bethesda

MS centers in Maryland

Compare treatment centers near a trial site by center type, providers and trials.

View Maryland centers
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play